Thyroid Eye Disease
Showing 26 - 34 of 34
Thyroid Eye Disease Trial in Baltimore (Celecoxib, artificial tears)
Terminated
- Thyroid Eye Disease
- Celecoxib
- artificial tears
-
Baltimore, MarylandWilmer Eye Institute, Johns Hopkins University
Jul 15, 2020
Corneal Tomographic Parameters in TGD
Completed
- Keratoconus
- +2 more
- Pentacam tomography
-
Mansoura, Dakahlia, EgyptMansoura University
Jun 15, 2020
Thyroid Eye Disease, Graves' Orbitopathy Trial in United States (Teprotumumab)
Approved for marketing
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
-
Beverly Hills, California
- +7 more
Mar 13, 2020
B-cell Depletion Therapy With Rituximab for Thyroid Eye Disease
Terminated
- Thyroid Eye Disease
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Nov 14, 2019
Thyroid Eye Disease Trial in Guangdong (Orbital decompression combined with MPT)
Unknown status
- Thyroid Eye Disease
- Orbital decompression combined with MPT
-
Guangdong, Guangdong, ChinaZhongshan Opthalmic Center
Sep 17, 2019
Thyroid Eye Disease, Ocular Hypertension, Glaucoma Trial in Stanford (Prostaglandin Analog, Timolol)
Withdrawn
- Thyroid Eye Disease
- +2 more
- Prostaglandin Analog
- Timolol
-
Stanford, CaliforniaStanford Hospital and Clinics
May 14, 2018
Disappearance of Graves' Orbitopathy
Completed
- Thyroid Eye Disease
- Ophthalmological evaluation
- Questionnaire
- (no location specified)
Mar 31, 2017
Thyroid Eye Disease Trial in La Jolla (SENSIMED Triggerfish)
Completed
- Thyroid Eye Disease
- SENSIMED Triggerfish
-
La Jolla, CaliforniaShiley Eye Center, University of California, San Diego
Feb 15, 2016
Thyroid Associated Ophthalmopathies, Graves´ Ophthalmopathy, Thyroid Eye Disease Trial in Spain (Tocilizumab (RoActemra®),
Completed
- Thyroid Associated Ophthalmopathies
- +2 more
- Tocilizumab (RoActemra®)
- Sterile 0.9% Sodium Chloride
-
Santiago de Compostela, A Coruña, Spain
- +8 more
Jan 19, 2016